tetano
Editor, Senior Moderator
EBioMedicine. 2019 Jan 30. pii: S2352-3964(19)30048-9. doi: 10.1016/j.ebiom.2019.01.041. [Epub ahead of print]
[h=1]Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival.[/h] Hallberg P[SUP]1[/SUP], Smedje H[SUP]2[/SUP], Eriksson N[SUP]3[/SUP], Kohnke H[SUP]4[/SUP], Daniilidou M[SUP]5[/SUP], ?hman I[SUP]6[/SUP], Yue QY[SUP]7[/SUP], Cavalli M[SUP]8[/SUP], Wadelius C[SUP]8[/SUP], Magnusson PKE[SUP]9[/SUP], Landtblom AM[SUP]5[/SUP], Wadelius M[SUP]4[/SUP]; Swedegene.
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The incidence of narcolepsy rose sharply after the swine influenza A (H1N1) vaccination campaign with Pandemrix. Narcolepsy is an immune-related disorder with excessive daytime sleepiness. The most frequent form is strongly associated with HLA-DQB1*06:02, but only a minority of carriers develop narcolepsy. We aimed to identify genetic markers that predispose to Pandemrix-induced narcolepsy.
[h=4]METHODS:[/h] We tested for genome-wide and candidate gene associations in 42 narcolepsy cases and 4981 controls. Genotyping was performed on Illumina arrays, HLA alleles were imputed using SNP2HLA, and single nucleotide polymorphisms were imputed using the haplotype reference consortium panel. The genome-wide significance threshold was p < 5 ? 10[SUP]-8[/SUP], and the nominal threshold was p < 0.05. Results were replicated in 32 cases and 7125 controls. Chromatin data was used for functional annotation.
[h=4]FINDINGS:[/h] Carrying HLA-DQB1*06:02 was significantly associated with narcolepsy, odds ratio (OR) 39.4 [95% confidence interval (CI) 11.3, 137], p = 7.9 ? 10[SUP]-9[/SUP]. After adjustment for HLA, GDNF-AS1 (rs62360233) was significantly associated, OR = 8.7 [95% CI 4.2, 17.5], p = 2.6 ? 10[SUP]-9[/SUP], and this was replicated, OR = 3.4 [95% CI 1.2-9.6], p = 0.022. Functional analysis revealed variants in high LD with rs62360233 that might explain the detected association. The candidate immune-gene locus TRAJ (rs1154155) was nominally associated in both the discovery and replication cohorts, meta-analysis OR = 2.0 [95% CI 1.4, 2.8], p = 0.0002.
[h=4]INTERPRETATION:[/h] We found a novel association between Pandemrix-induced narcolepsy and the non-coding RNA gene GDNF-AS1, which has been shown to regulate expression of the essential neurotrophic factor GDNF. Changes in regulation of GDNF have been associated with neurodegenerative diseases. This finding may increase the understanding of disease mechanisms underlying narcolepsy. Associations between Pandemrix-induced narcolepsy and immune-related genes were replicated.
Copyright ? 2019. Published by Elsevier B.V.
[h=4]KEYWORDS:[/h] (MeSH); Autoimmune diseases; Drug-related side effects and adverse reactions; Genetic variation; Genome-wide association study; Glial cell line-derived neurotrophic factor; H1N1 subtype; Influenza A virus; Influenza vaccines; Narcolepsy; Pharmacogenetics; RNA, long noncoding
PMID: 30711515 DOI: 10.1016/j.ebiom.2019.01.041
Free full text
[h=1]Pandemrix-induced narcolepsy is associated with genes related to immunity and neuronal survival.[/h] Hallberg P[SUP]1[/SUP], Smedje H[SUP]2[/SUP], Eriksson N[SUP]3[/SUP], Kohnke H[SUP]4[/SUP], Daniilidou M[SUP]5[/SUP], ?hman I[SUP]6[/SUP], Yue QY[SUP]7[/SUP], Cavalli M[SUP]8[/SUP], Wadelius C[SUP]8[/SUP], Magnusson PKE[SUP]9[/SUP], Landtblom AM[SUP]5[/SUP], Wadelius M[SUP]4[/SUP]; Swedegene.
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] The incidence of narcolepsy rose sharply after the swine influenza A (H1N1) vaccination campaign with Pandemrix. Narcolepsy is an immune-related disorder with excessive daytime sleepiness. The most frequent form is strongly associated with HLA-DQB1*06:02, but only a minority of carriers develop narcolepsy. We aimed to identify genetic markers that predispose to Pandemrix-induced narcolepsy.
[h=4]METHODS:[/h] We tested for genome-wide and candidate gene associations in 42 narcolepsy cases and 4981 controls. Genotyping was performed on Illumina arrays, HLA alleles were imputed using SNP2HLA, and single nucleotide polymorphisms were imputed using the haplotype reference consortium panel. The genome-wide significance threshold was p < 5 ? 10[SUP]-8[/SUP], and the nominal threshold was p < 0.05. Results were replicated in 32 cases and 7125 controls. Chromatin data was used for functional annotation.
[h=4]FINDINGS:[/h] Carrying HLA-DQB1*06:02 was significantly associated with narcolepsy, odds ratio (OR) 39.4 [95% confidence interval (CI) 11.3, 137], p = 7.9 ? 10[SUP]-9[/SUP]. After adjustment for HLA, GDNF-AS1 (rs62360233) was significantly associated, OR = 8.7 [95% CI 4.2, 17.5], p = 2.6 ? 10[SUP]-9[/SUP], and this was replicated, OR = 3.4 [95% CI 1.2-9.6], p = 0.022. Functional analysis revealed variants in high LD with rs62360233 that might explain the detected association. The candidate immune-gene locus TRAJ (rs1154155) was nominally associated in both the discovery and replication cohorts, meta-analysis OR = 2.0 [95% CI 1.4, 2.8], p = 0.0002.
[h=4]INTERPRETATION:[/h] We found a novel association between Pandemrix-induced narcolepsy and the non-coding RNA gene GDNF-AS1, which has been shown to regulate expression of the essential neurotrophic factor GDNF. Changes in regulation of GDNF have been associated with neurodegenerative diseases. This finding may increase the understanding of disease mechanisms underlying narcolepsy. Associations between Pandemrix-induced narcolepsy and immune-related genes were replicated.
Copyright ? 2019. Published by Elsevier B.V.
[h=4]KEYWORDS:[/h] (MeSH); Autoimmune diseases; Drug-related side effects and adverse reactions; Genetic variation; Genome-wide association study; Glial cell line-derived neurotrophic factor; H1N1 subtype; Influenza A virus; Influenza vaccines; Narcolepsy; Pharmacogenetics; RNA, long noncoding
PMID: 30711515 DOI: 10.1016/j.ebiom.2019.01.041
Free full text